ICIS2017 The 5th Annual Meeting of the International Cytokine and Interferon Society

 Call for Abstracts

The ICIS 2017 Scientific Programme Committee and Organising Committee welcome all the delegates to submit abstracts of original contributions for oral and poster presentations at the 5th Annual Meeting of the International Cytokine and Interferon Society (ICIS 2017) co-organized by JSICR and MMCB.

Abstract Submission Guideline

The corresponding topic must be selected to ensure correct scoring of the abstract. The content of the abstract must be topic related. A paper should not be submitted to the 5th Annual Meeting of the International Cytokine and Interferon Society (ICIS2017) if the full paper has been already published.


Abstracts will be accepted for the all subjects related to cytokine (= cytokine, interferon, and chemokine) research. Please select a corresponding topic from following categories for your submitted abstract;

  • Innate immunity and infection
    *Key words: Pathogen recognition, vaccine, host defense, PRR, PAMPs, IFNs, virus, bacteria, infection, vaccines
    Chair: Shinobu Saijo (Chiba University, Japan) , Mitsutoshi Yoneyama (Chiba University, Japan)
  • Allergic disease
    *Key words: Th2, allergy, asthma, airway inflammation, food allergy, tolerance, chemical mediators, therapy, mast cell
    Chair: Hiroshi Nakajima  (Chiba University, Japan) , David Vöhringer (Infektionsbiologische Abteilung am Institut für Medizinische Mikrobiologie, Germany)
  • Cytokines in skin inflammatory diseases
    *Key words: psoriasis, skin barrier, atopic dermatitis, DC, Langerhans cell, IL-17, IL-22, IL-23, resident microbes
    Chair: Masayuki Amagai (Keio University, Japan) , Kristin M. Leiferman (FAAD and FAAAAI University of Utah Health Care, USA)
  • Regulation of Cytokine Production
    *Key words: mRNA, protein, degradation, proteasome, transcription factor
    Chair: Osamu Takeuchi (Kyoto Univeristy, Japan) , Howard Young (Center for Cancer Research, National Cancer Institute, USA)
  • Genetic disorders in cytokines and inflammation
    *Key words: autoinflammation, inflamasome, immunodeficiency
    Chair: Koji Yasutomo (Tokushima University, Japan) , Warren Leonard (NIH, USA)
  • Cytokines in mucosal immunity
    *Key words: IBD, IEL, lamina propria, DC, macrophage, oral tolerance, colitis
    Chair: Yoichiro Iwakura (Tokyo University of Science, Japan) , Rachel R. Caspi (NIH, USA)
  • Signal transduction and metabolic regulation
    *Key words: kinase, phosphatase, ubiqutination, inflammasome, metabolism, mTOR, oxygen
    Chair: Akihiko Yoshimura (Keio University, Japan) , Xiaoxia Li (Cleveland Clinic Lerner Research Institute, USA)
  • Cytokines, inflammatory factors, and macrophages in host defense
    *Key words: mucosal immunity, colitis, infection, Tregs, PGE2, helminth, Th17
    Chair: Kiyoshi Takeda (Osaka University Graduate School of Medicine, Japan) , Christopher Hunter (University of Pennsylvania, USA)
  • Anti-cytokine therapy for inflammatory human diseases
    *Key words: RA, anti-cytokine therapy, IL-6, TNFa, RANKL, IL-23
    Chair: Yoshiya Tanaka (University of Occupational and Environmental Health, Japan) , John A Hamilton (The Royal Melbourne Hospital, University of Melbourne, Australia)
  • Cytokines in autoimmune diseases
    *Key words: neuro inflammation, kidney disease, blood vessels
    Chair: Masaaki Murakami (Hokkaido University, Japan) , Ann Chen (Tri-Service General Hospital, National Defense Medical Center, Taiwan)
  • Emerging cytokines
    *Key words: IL1 family, IL-10 family, IL-33, IL-34, IL-35, IL-27
    Chair: Hiroki Yoshida (Saga University, Japan) , Cem Gabay  (University of Geneva School of Medicine, Switzerland)
  • Helper T cell differentiation
    *Key words: Th1, Th2, Th17, Tfh, Treg, transcription factors, Foxp3
    Chair: Masato Kubo (Tokyo University of Science, Japan) , Motoko Kimura (Chiba University, Japan)
  • Development and function of Macrophage and DC
    *Key words: inflammatory monocytes, precursor, resident macrophage, chemokines
    Chair: Toshiaki Ohteki (National University Corporation Tokyo Medical and Dental University, Japan) , Miriam Merad (Icahn School of Medicine at Mount Sinai, USA)
  • Cytokines in cancer development and antitumor immune therapy
    *Key words: immune checkpoints, CART, Tregs, Myeloid suppressors, CTL, tumor growth factors
    Chair: Tsukasa Seya (Hokkaido University Graduate School of Medicine, Japan) , Christopher Klebanoff (National Cancer Institute, USA)
  • Innate cells including ILC, NK, mast cell and γδT cells
    *Key words: ILC, NK, mast cell, γδT cells
    Chair: Shinichiro Sawa (Hokkaido University, Japan) , Kazuyo Moro (RIKEN IMS, Japan)
  • Others

Presentation Style

You may specify the preference for presentation style from “Poster only” or “Oral or Poster”.

In the latter, the Program Committee is responsible for the selection of Oral or Poster.

"Oral Session" will be Workshops corresponding to the topics. Please refer to the chairs for each workshop session.


English only

Maximum Number of Words

Abstract Title: limited to 30 words

For standardization, the acceptable length of the body of the abstract is of maximum 300 words.


Tables, graphs, images, and references are not allowed.

Please follow the instructions to submit an abstract for the ICIS2017.

  • Abstracts must be submitted via the abstract submission system only.
    *Abstracts submitted by email, fax, or post will NOT be accepted.
  • In order to log onto the submission site, you must have a username and password. Your login information will be sent to you by e-mail when creating your account on the site.
  • Abstract title must brief and identify the nature of study.
  • Abstract must contain original materials, not published or presented at any other international congress prior to the ICIS 2017.
  • Do not insert a space at the beginning of a paragraph.
  • Submitted abstracts can be modified at any time before the deadline date.
  • The first author will be a presenting author.

Abstract Submission Deadline

The deadline to submit abstracts will be 26 June, 2017, Monday at 23:59 JST.

The deadline is extended to 3 July, 2017, Monday at 23:59 ST.

Abstract submission has been closed. Thank you for many submissions.

Notification of acceptance

All abstract submitters will be notified to the registered e-mail address by the end of July, 2017 whether the abstracts have been accepted. If you do not receive a notification by the date mentioned, please contact the ICIS201 Abstract Team at: joefner@cytokinesociety.org

Abstract Awards by the ICIS2017

Application for Kishimoto Travel Awards has been closed.
Email notification will be sent in mid September.

  • Kishimoto Travel Awards

    40 travel awards of 100,000 JPY (~900 USD) each will be offered to international attendees and 20 travel awards of 50,000 JPY each will be offered to attendees based in Japan.
    Applicants should be under 40 years of age at the time of the meeting. Young investigators including graduate students are especially encouraged to apply.

    The selection process will be conducted by local program committee members based on the applicant's abstract, CV, reasons for applying, and geographical location. Applicants who secure another ICIS travel award to attend ICIS2017 will be ineligible to receive this award.

    To apply for these travel awards, applicants should send the following items to the ICIS2017 Secretariat (info@icis2017japan.com).

    1) A copy of their submitted abstract with abstract confirmation number and meeting registration number.

    2) A brief CV including 3 selected publications. The applicant's name and affiliation should be clearly stated on the CV.

    3) A brief statement explaining why the applicant is applying for the travel award.

    The awardees will be announced on the first day of ICIS2017. Successful awardees must collect their award from the registration desk in person during the meeting. 

    The deadline for application will be 31 August, 2017, Thursday at 23:59 JST.
    All the submittals need to be sent to the secretariat before the deadline.

  • JLB award
    JLB award will be selected for 2 oral/poster presentations during the meeting.
    Awardees will receive 500USD.

Travel Awards by the International Cytokine & Interferon Society

The International Cytokine & Interferon Society originally hosts Travel Awards.

For details and eligibility requirements about the Travel Awards, please visit the International Cytokine & Interferon Society Webpage: Click Here

You must apply to the Travel Awards via regsitration site of the congress.


JLB Dedicated Meeting Issue

Be a part of a Special JLB Dedicated Meeting Issue!

The Journal of Leukocyte Biology (JLB) will publish a cluster of articles related to topics of the 5th Annual Meeting of the International Cytokine and Interferon Society, ICIS 2017, both review papers ("overviews") and original investigations. Selected contributions will be invited soon after the completion of the conference, and all submitted manuscripts will be peer-reviewed according to the high standards of the JLB.

The Journal of Leukocyte Biology (JLB) publishes original experimental and clinical research that provides new insights into the function of leukocytes and/or stromal cells at the molecular, structural, cellular and systemic level. The Journal scope includes all leukocytes (granulocytes, monocytes/macrophages, dendritic cells, T, B and innate lymphoid or NK/NKT cells) and/or leukocyte products together with associated stromal (endothelial, epithelial) cells studied in vitro and in the context of innate and adaptive immunity, development, homeostasis, host-pathogen interactions, immunotherapy and immunopathogenesis (in both vertebrate models and/or human studies). Pathologies of interest include immunodeficiency, autoimmunity, allergy, cancer, trauma, infections, inflammatory and iatrogenic diseases. JLB also publishes basic, translational and clinical reviews as well as commentaries on current journal content.

Participants may submit their work for the dedicated issue according to the following schedule:

5th Annual Meeting of the International Cytokine and Interferon Society, ICIS 2017 in Kanazawa, Japan from Oct.29th to Nov. 2nd.

  • Invitations to be sent by Nov. 15, 2017 – Responses due by Dec. 1
  • First submissions are due by March 1, 2018
  • First review by May 1, 2018
  • Revised papers will be expected by July 1, 2018
  • Articles to be re-reviewed by Sept. 1, 2018
  • All articles accepted by Sept. 1 will publish in November 2018


Please contact the ICIS2017 Abstract Team at joefner@cytokinesociety.org for all enquiries about abstracts and/or in the case if you do not receive a confirmation e-mail after submitting an abstract.

ICIS2017 Abstract Desk

E-mail: joefner@cytokinesociety.org

Office hour: 10:00 - 17:30 CET Monday - Friday